Skip to main content
Figure 3 | Clinical Proteomics

Figure 3

From: Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients

Figure 3

Validation of differentially expressed proteins by western blot. Western blot analysis of A C1 inhibitor, B transthyretin and C apolipoprotein A-I. The levels of a C1 inhibitor, b transthyretin and c apolipoprotein A-I in individual samples of each group detected by Western blot. Graphical representation of the semi quantitative analysis of Western blot results (mean ± SD of OD of bands). d Relative abundance of C1 inhibitor: control, 33920.4 ± 8991.7, visceral leishmaniasis, 54101.0 ± 27858.3, p < 0.01. e relative abundance of transthyretin: control, 22236.7 ± 2794.3, visceral leishmaniasis, 12804.3 ± 6128.6, p < 0.0001. and f relative abundance of apolipoprotein A-I: control, 7962.7 ± 3462.2, visceral leishmaniasis, 4846.4 ± 2319.1, p < 0.05

Back to article page

Clinical Proteomics

ISSN: 1559-0275